Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma
- PMID: 28351314
- DOI: 10.1177/1010428317695025
Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma
Abstract
This study aimed to investigate the inactivation of the parkin gene by promoter methylation and its relationship with genome instability in nasopharyngeal carcinoma. Parkin was considered as a tumor suppressor gene in various types of cancers. However, its role in nasopharyngeal carcinoma is unexplored. Genomic instabilities were detected in nasopharyngeal carcinoma tissues by the random amplified polymorphic DNA. The methylation-specific polymerase chain reaction, semi-quantitative reverse transcription polymerase chain reaction, and immunohistochemical analysis were used to detect methylation and mRNA and protein expression of parkin in 54 cases of nasopharyngeal carcinoma tissues and 16 cases of normal nasopharyngeal epithelia tissues, and in 5 nasopharyngeal carcinoma cell lines (CNE1, CNE2, TWO3, C666, and HONE1) and 1 normal nasopharyngeal epithelia cell line (NP69). mRNA expression of parkin in CNE1 and CNE2 was analyzed before and after methyltransferase inhibitor 5-aza-2-deoxycytidine treatment. The relationship between promoter methylation and mRNA expression, demethylation and mRNA expression, and mRNA and protein expression of the gene and clinical factors and genomic instabilities were analyzed. The mRNA and protein expression levels were significantly reduced in 54 cases of human nasopharyngeal carcinoma compared with 16 cases of normal nasopharyngeal epithelia. Parkin-methylated cases showed significantly lower mRNA and protein expression levels compared with unmethylated cases. After 5-aza-2-deoxycytidine treatment, parkin mRNA expression was restored in CNE1 and CNE2; 92.59% (50/54) of nasopharyngeal carcinoma demonstrated genomic instability. Parkin is frequently inactivated by promoter methylation, and its mRNA and protein expression correlate with lymph node metastasis and genomic instability. Parkin deficiency probably promotes tumorigenesis in nasopharyngeal carcinoma.
Keywords: Genome instability; lymph node metastasis; nasopharyngeal carcinoma; parkin gene; promoter methylation.
Similar articles
-
[Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].Zhonghua Zhong Liu Za Zhi. 2016 Nov 23;38(11):812-817. doi: 10.3760/cma.j.issn.0253-3766.2016.11.003. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27998438 Chinese.
-
Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.Int J Cancer. 2007 Jan 1;120(1):32-8. doi: 10.1002/ijc.22185. Int J Cancer. 2007. PMID: 17013896
-
Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma.Biol Res. 2019 Jun 10;52(1):31. doi: 10.1186/s40659-019-0238-3. Biol Res. 2019. PMID: 31182157 Free PMC article.
-
Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.Int J Cancer. 2005 Jan 20;113(3):386-92. doi: 10.1002/ijc.20593. Int J Cancer. 2005. PMID: 15455391
-
Inactivation of MSH3 by promoter methylation correlates with primary tumor stage in nasopharyngeal carcinoma.Int J Mol Med. 2017 Sep;40(3):673-678. doi: 10.3892/ijmm.2017.3044. Epub 2017 Jun 27. Int J Mol Med. 2017. PMID: 28656302 Free PMC article.
Cited by
-
Parkinson's disease-associated protein Parkin: an unusual player in cancer.Cancer Commun (Lond). 2018 Jun 26;38(1):40. doi: 10.1186/s40880-018-0314-z. Cancer Commun (Lond). 2018. PMID: 29941042 Free PMC article. Review.
-
Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients.BMC Cancer. 2019 Aug 20;19(1):820. doi: 10.1186/s12885-019-6013-6. BMC Cancer. 2019. PMID: 31429726 Free PMC article.
-
The Links between Parkinson's Disease and Cancer.Biomedicines. 2020 Oct 14;8(10):416. doi: 10.3390/biomedicines8100416. Biomedicines. 2020. PMID: 33066407 Free PMC article. Review.
-
Head and Neck Cancer: A Potential Risk Factor for Parkinson's Disease?Cancers (Basel). 2024 Jul 8;16(13):2486. doi: 10.3390/cancers16132486. Cancers (Basel). 2024. PMID: 39001548 Free PMC article.
-
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.Int J Oncol. 2022 Feb;60(2):20. doi: 10.3892/ijo.2022.5310. Epub 2022 Jan 21. Int J Oncol. 2022. PMID: 35059737 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources